News
NICE backs Keytruda/Padcev combo for bladder cancer
Patients with muscle-invasive bladder cancer can now receive NHS treatment with MSD's Keytruda and Astellas' Padcev, given before and after surgery.
News
What do midterms mean for Trump's pharma and health agenda?
As Democrats flip the Senate and House in a blue tsunami, we look at Trump's health and pharma policies that will likely see scrutiny and pushback.
News
EVERSANA builds its AI Agency with Estima acquisition
EVERSANA has acquired UK AI-powered health economics and outcomes research (HEOR) firm Estima to help its customers "modernise commercialisation."
News
uniQure set for May FDA verdict on Huntington's gene therapy
The FDA has started its review of uniQure's gene therapy for neurodegenerative disorder Huntington's, but will require an advisory committee meeting.
News
Ultragenyx gets first Euro nod for rare disease drug Dojolvi
Several years after its US approval, Ultragenyx's therapy for long-chain fatty acid oxidation disorders, Dojolvi, has been greenlit in the UK.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
